Search companies

Live

Tuesday, 17 November 2026 · 583 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Recce Director to Retire as Options Offers Open

RCE: $0.335 +0.00% · MC: $113M

Recce Pharmaceuticals director Alistair McKeough will retire after the November 6 AGM and will not seek re-election; the company has withdrawn the related resolution, and Alan Dunton will take over as Audit and Risk Committee chair. A prospectus also opens offers of unlisted options linked to the earlier placement, including up to 10 million additional options if attaching options are exercised.

Source announcements: 2026-11-04 09:38 to 2026-11-04 18:49 Sydney time
Story updated 2026-11-04 18:55 Sydney time
SourcesOptions ProspectusRetirement of Mr Alistair McKeough as Non-Executive Director
Comments